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Microglia, the resident macrophages in the central nervous system (CNS), have 
been shown to play an important role in the regulation of immune and inflammatory 
activities as well as tissue remodeling in the CNS. In response to a variety of stimuli, 
microglia undergo rapid proliferation, become hypertrophic and secrete a number of 
proinflammatory cytokines, including tumor necrosis factor-α (TNF-α), interleukin-1β 
(IL-1β), and cytotoxic molecules such as nitric oxide (NO) and reactive oxygen species.   
Microglial activation has been reported in a variety of neurodegenerative diseases such as 
Alzheimer’s disease, Parkinson’s disease and ischemic injury (Uno et al., 1997; Jellinger, 
2000; Matsuoka et al., 2001). β-amyloid peptides (Aβ), HIV coat protein gp120, prion 
protein-derived peptides have also been reported to be associated with various 
neurodegenerative diseases via the neurotoxic factors released by microglia (Brown, 2001; 
Qin et al., 2002; Gao et al., 2002). In culture, lipopolysacharide (LPS) and Aβ1-42 peptides 
have been widely used for the activation of microglia which release neurotoxic and 
proinflammatory mediators (Bronstein et al., 1995; Araki et al., 2001; Liu et al., 2002). 
Although microglia play a beneficial role in neuronal cell viability and survival by 
producing growth factors and removing potentially toxic cellular debris, several studies 
have demonstrated that activated microglia can be deleterious to neurons through 
excessive production of inflammatory mediators (Boje et al., 1992; Chao et al., 1992; Hao 
et al., 2001). Hence, an understanding of the mechanisms that regulate microglial 
activation is an important step to develop therapeutic strategies that prevent the 
neurodegenerative diseases.  
Several lines of evidence showed that retinoic acid (RA) exerts an anti-
inflammatory effect and attenuates the production of inflammatory mediators such as 




regulation of cell proliferation and differentiation (Mehta et al., 1994; Datta et al., 2001). 
It is well known that RA modulates the target cell activity by binding to one of its two 
nuclear receptors: retinoic acid receptors (RAR- α, β, γ) and retinoid X receptors (RXR- 
α, β, γ. RAR or RXR may modulate gene transcription by directly binding to promoters 
containing a retinoic acids receptor element (RARE) or via antagonistic cross-coupling of 
transcription factors such as NF-κB (Xu et al., 1997). Recent studies have demonstrated 
that RA receptors regulate inflammation in different cell types (Motomura et al., 2001; 
Grummer et al, 2000). In addition, expression of RARβ was detected in the rodent brain 
(Ree et al., 1992). In view of these observations, it is hypothesized that RA may modulate 
the inflammatory response of microglia in primary cultures. Hence, we have investigated 
the effects of RA on microglial activation and their secretions of inflammatory cytokines 
as well as NO in primary cultures using immunohistochemistry and Real Time PCR. 
Exposure of primary cultures of rat microglial cells to Aβ or LPS stimulated the mRNA 
expression levels of TNF-α and iNOS significantly. RA decreased both TNF-α and iNOS 
mRNA expression levels in microglia exposed to Aβ or LPS in a dose-dependent manner 
(0.1-10µM). The anti-inflammatory effects of RA were correlated with the enhancement 
of the retinoic acid receptor-β (RAR-β), and transforming growth factor-β1 (TGF-β1) 
expressions as well as the inhibition of NF-κB translocation.  These results suggest that 
RA may inhibit the neurotoxic effect of activated microglia by suppressing their secretion 
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The central nervous system (CNS) contains a unique population of resident 
macrophages termed microglia, representing approximately 5-12% of all glia found in 
the brain. These cells play a prominent role in infectious, traumatic, inflammatory, 
ischemic and degenerative CNS processes. During their life cycle, microglia display 
considerable phenotypic heterogeneity, i.e. they may be ameboid, ramified or reactive, 
the latter form being found in pathological conditions. Ameboid microglia are 
abundant in the developing brain and phenotyically similar to reactive microglia with a 
large spherical cell body and short processes. During postnatal stages of development, 
the ameboid microglia transform into ramified microglia with several long processes.  
Upon activation by inflammatory stimuli, the ramified microglia undergo a series of 
morphological and functional changes in order to mobilize the cellular and molecular 
defense system of the CNS. The reactive or activated microglia, which appear as full-
blown phagocytes, express various cytokines and growth factors in order to respond to 
neural injury in pathological conditions. Although del Rio-Hortega (1932) provided a 
complete framework for defining the microglia, many questions of this cell type 
remain unknown. An example is the origin of microglial precursors. At least there are 
two hypothesizes, one stating that microglial cells are of mesodermal origin; the other 
proposing that microglial cells originate from neuroepithelial cells. The former 
statement is sustained by a large proportion of authors, who believe that microglia 
derive either from monocytes that leave the blood stream and colonize the nervous 
parenchyma, or from primitive (or stem) hemopoietic cells that differentiate as 
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1.1. Origin of microglia 
1.1.1. Origin from monocytes/macrophages 
Microglial cells and cells of monocytic lineage share several features, such as 
the presence of particular enzymes, the nucleoside diphosphatase, non-specific esterase 
and acid phosphatase (Ling et al., 1982; Fujimoto et al., 1989; Castellano et al., 1991). 
Microglial and monocytic cells contain large amounts of vault particles (Chugani et al., 
1991) and are labeled by several types of lectins (Hutchins et al., 1990; Acarin et al., 
1994). Moreover, antibodies that recognize both microglia and monocytic cells have 
been developed in a number of species, such as fish (Dowding et al., 1991), 
amphibians (Goodbrand and Gaze, 1991), birds (Jeurissen et al., 1988; Cuadros et al., 
1992), rodents (Imamura et al., 1990; Gehrmann and Kreutzberg, 1991; Perry and 
Gordon, 1991; Flaris et al., 1993) and humans (Penfold et al., 1991; Paulus et al., 
1992). These findings, together with the phagocytic properties of microglial cells, 
suggest that microglia are related to monocytic cells and belong to the mononuclear 
phagocytic system. 
Ling and coworkers (1979; 1980) in their experiment found the carbon-labeled 
monocytes injected into the blood stream of newborn rats in the ameboid and ramified 
microglia and hence they concluded that microglia originated from monocytes which 
enter the nervous parenchyma from the blood stream. 
Various studies support the idea that microglial cells are of 
monocyte/macrophage lineage. Cells with morphological features of microglia and 
with a pattern of membrane potentials characteristic of microglia develop from 
monocytes or non-nervous tissue macrophages which are cultured on an astrocyte 
monolayer (Schmidtmayer et al., 1994; Sievers et al., 1994). At present, it is not 
known whether all cells of the macrophage/monocyte lineage can produce microglia 
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cells, or whether this ability is limited to a special subset of such cells. Giulian et al. 
(1995) found that mononuclear phagocytes isolated from the brain of newborn rats 
gave rise to cells with particular morphological features which did not appear in 
cultured mononuclear phagocytes from non-nervous sources; these authors concluded 
that microglial precursors are unique class of cell different from precursors of other 
types of mononuclear phagocytes. In this connection, it was found that a subpopulation 
of bone marrow-derived cells showed the same ion channel pattern as microglial cells, 
suggesting that the bone marrow contains precursors that are committed to produce 
microglia and that they are different from the precursors which produce macrophages 
for other body regions (Banati et al., 1991). 
However, macrophages/microglial cells appear within the CNS before it is 
vascularized (Ashwell, 1991; Sorokin et al., 1992; Cuadros et al., 1993; Wang et al., 
1996) and before monocytes are produced in hemopoietic tissues (Sorokin et al., 1992; 
Naito et al., 1996). Therefore, it has been suggested that not all microglial cells can 
originate from circulating monocytes during development. Another possibility is that 
some or all microglial cells derive from undifferentiated hemopoietic cells that 
colonize the developing CNS independently of its vascularization (Hurley and Streit, 
1996). In this regard Alliot et al. (1991) noted that hemopoietic cells that can 
differentiate into microglial cells are present in the bone marrow and in the nervous 
parenchyma of both adult and developing CNS of mice. The presence of macrophages 
of hemopoietic origin within the early nervous parenchyma has been established using 
quail–chick embryo chimeras (Cuadros et al., 1993). Although it is possible that these 
embryonic macrophages give rise to the population of microglial cells in the adult, the 
connection between them and microglial cells has not been conclusively established. In 
fact, embryonic macrophages might also leave the CNS or degenerate after fulfilling 
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their functions during development, and therefore they would not be microglial 
precursors. 
1.1.2. Origin from neuroectodermal cells 
Several authors have sustained that at least some microglial cells are of 
neuroectodermal lineage. Autoradiographic analyses of the genesis of microglia within 
the mouse hippocampus showed that microglial cells seemed to derive from glioblasts 
that also produce astrocytes; this conclusion was based on a presumed continuous 
morphological transition from proliferating glioblasts to resting microglia (Kitamura et 
al., 1984). The finding of microglial cells within the matrix cell layer during 
development has been considered as an indication of the neuroepithelial origin of 
microglia (Hutchins et al., 1990). However, the microglial cells within the 
neuroepithelium may also be cells that are traversing the neuroepithelial layer after 
entering the nervous parenchyma from the ventricle (Cuadros et al., 1994). 
It was found that monoclonal antibodies against the protein lipocortin-1 label 
both a fraction of neuroepithelial cells and microglial cells in the developing rat brain, 
suggesting that microglial cells originate within the neuroepithelium (Fedoroff, 1995). 
In addition, some of the antibodies that recognize microglial cells also label a 
proportion of cells of neuroectodermal origin (Dickson and Mattiace, 1989; McKanna, 
1993; Navascues et al., 1994; Wolswijk, 1995). Although these observations appear to 
support the idea that microglial cells are of neuroectodermal lineage, it should be 
recalled that sharing some antigenic markers does not mean that the two cell types also 
share the same origin.  
It has been shown that macrophage-like cells and/or microglia are produced in 
cultures of embryonic neuroepithelium (Hao et al., 1991; Richardson et al., 1993; 
Papavasiliou et al., 1996), suggesting that microglial cells may derive from embryonic 
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neuroepithelial cells. Moreover, macrophage/microglial cells were produced in mouse 
neuroepithelial cell cultures which are free of potential microglial precursors of 
mesenchymal origin after selective elimination of cells bearing the Mac-1 antigen, 
present in macrophages and microglial cells (Hao et al., 1991). However, the 
macrophage-like cells produced in these cultures might derive from Mac-1 negative -
cells which had previously invaded the developing CNS. In this connection Alliot et al. 
(1991) inferred that microglial cells may derive from cells in the nervous parenchyma 
which have not yet acquired the Mac-1 epitope. 
 
1.2. Types of Microglia 
Microglia constitute a significant proportion of the entire population of cells in 
the adult mammalian CNS (Lawson et al., 1990; McKanna 1993). These cells are 
found throughout the adult CNS parenchyma and are usually process bearing, thus the 
term "ramified" microglia (Fig 1.1). They are morphologically quite distinctive, having 
a relatively small cell body and displaying several fine irregular processes with 
numerous short branches and spiny-like projections. The number of primary processes 
and their complexity is considerably variable and to some extent region or location 
specific (Lawson et al., 1990). They are also notably distinguishable from other CNS 
cells by a particularly heterochromatic nucleus. The various adult parenchymal cells 
may also be referred to as "quiescent" or "resting" microglia, distinguishing them from 
others that arise in pathological states. The latter terms appropriately reflect the fact 
that these cells are highly downregulated in the expression of antigenic markers and 
functional indicators associated with macrophages (Thomas 1992; Streit et al., 1988).   
In the developing CNS, microglia appear “round”, “amoeboid”, and 
“pseudopod”. In comparison to the adult ramified microglia, these cells are more like 
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the classic macrophages as seen in other tissues. They express a wide array of 
antigenic markers in common with other mononuclear phagocyte populations. It has 
been suggested that this macrophages-like microglia type is principally involved in the 
removal of cellular debris generated by cell death of neurons, macroglia, and/or 
neuroepithelial cells in the developing CNS (Ashwell 1990; Ferrer et al., 1990). 
 
Fig 1.1. Microglia classics. From left to right, transformation of resting microglia into 
activated cells. (Adapted from Kreutzberg 1996 ) 
 
The resting or quiescent microglia of the adult appear to be exquisitely 
sensitive to pathologic conditions and may become an "activated" microglia cell. This 
involves both a morphologic and functional transformation. The delicate ramified 
appearance begins to withdraw, the cell body enlarges, and cells may reenter the cell 
cycle to undergo mitotic division. There is a remarkable upregulation of expression of 
immune-related and other antigenic macrophage markers. The cell becomes migratory 
and may ultimately become a full-blown macrophage-like phagocyte resembling the 
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ameoeboid class of microglia (Moore and Thomas 1996; McGeer et al., 1993; 
Gehrmann et al., 1995).  
Microglia are highly mutable cells that can take on a wide variety of 
phenotypes in vivo as discussed above. They display similar diversity in cell culture. 
Their distinctive morphologies are described as visualized by phase-contrast optics 
(Dobrenis, 1998): 
1. Type 1 - This type is a relatively large flattened cell with a circular to oval 
profile. It has been referred to as macrophages, "pancake-shaped" and 
amoeboid. This is one of the major microglial types seen in the first few days in 
vitro, though they may also persist for months in varying abundance depending 
on the specifics of the preparation. The cell may extend several extremely fine 
short spine-like projections or a extremely long thicker single process ending in 
a large fan-like terminal.  
2. Type-2 is a cell with a long, almost tubular or rod-shaped appearance. This is 
phase dark or gray and shows variable degrees of flattening. Either end may 
terminate in a flattened membranous expansion or tuft of spinous projections. 
3. Third type is a medium to large round cell with a vacuolated appearance. 
4. Type 4 is similar to the previous type, but this type also bears short 
lamellipodia, giving it an uneven circular profile at low magnification. At 
higher magnificantion these furly structures can clearly be seen, resembling 
paddles and often arising in several spots on the cell. 
5. Type 5 is very small (<10µm in diameter) round cell with one or two very fine 
short processes. 
6. Type-6 is relatively small; rather dark, irregular cell with two or three short 
thick, pseudopodium-like processes bearing lamillipodial-like terminals. 
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7. Type 7 has more of a star-shaped appearance with light gray to bright cell body 
and many short, somewhat tapering processes. 
8. Finally, Type 8 cell resembles a ramified microglia cells. This is several fine- 
to medium-caliber processes of greater length than those of type 6 and 7, which 
may display short branches or spines. The cell body is often relatively small, 
but depending on how the process arises, may appear to be large.  
 
1.3. Markers expressed by microglia 
Microglia express a wide range of surface and cytoplasmic markers that make 
them distinct. Both rat and human microglia were found to express the complement 
receptor C3b, which is involved in the binding of complement opsonised particles. 
Adult human and neonatal rat microglia expressed macrophage cytoplasmic antigens 
(EBM-11 and ED 1, antibodies respectively) (William et al., 1992). Complement 
receptor C3b was also found to be expressed intensely in amoeboid microglia in the 
early postnatal rat although the staining intensity diminished in the late postnatal 
period as the cell becomes ramified (Ling et al., 1990). Human microglia express 
MHC (major histocompatibility complex) class I antigens (Hayes et al., 1987). This is 
in contrast with rat microglias, which express little or no MHC II constitutely, although 
expression can be induced by treatment with interferon-γ (IFN-γ) (Woodroofe et al., 
1989). Non-specific esterase is often used as markers for monocytes and it is also 
expressed by amoeboid microglia but not by adult ramified microglia (Hayes et al., 
1988; Thomas, 1992). Other commonly used markers for both the ramified and the 
amoeboid microglia are the plant lectins, B4 isolectin and agglutin-120. These lectins 
bind to the D-galactose in microglia and, within the brain parenchyma, do not label 
neurons, astrocytes, or oligodentrocytes (Thomas, 1992). 
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1.4. Factors that trigger microglial activation 
Viral envelopes, bacterial cell wall components, and other infectious agents 
(prion protein) cause macrophage/microglial activation (Heppner et al., 2001). 
Lipopolysaccharides (LPS) of gram-negative bacteria serve as standard agents in 
mimicking infections.  
CNS injury liberates signals that instruct microglial transformation. Trauma 
signals can be subtle and affect microglia in the vicinity of neuronal somata while the 
primary insult is set farther away (Streit 2000). Microglial activation might be initiated 
or modified by molecules commonly released in neurotransmission (Fields and 
Stevens, 2000; Honda et al., 2001). CNS injury may release factors (including 
cytokines) that are bound to the extracellular matrix in a functionally silent pool, but 
carry latent microglia-activating signal character. 
Disease-related production, processing, and aggregation of proteins, such as 
amyloid-β (Aβ) in Alzheimer disease (AD), can stimulate microglia, including its 
release properties. In conjunction with other stimuli, aggregates seem to irritate 
microglial cells chronically as they concentrate around senile plaque (SP), the major 
pathological lesion of AD. Clusters of activated microglia then produce factors (such 
as Interleukin-1 or IL-1, Tumor Necrosis Factor-α or TNF-α) that can drive neurotoxic 
cascades which in turn recruit more microglia.  
Microglial activation is basically a beneficial, physiologically approved 
reaction aiming at protection and restoration of endangered CNS structures and 
functions. Only excessive or sustained stimulation will lead to pathological changes in 
the CNS. Many products released by the microglia, such as reactive nitrogen and 
oxygen intermediates, are toxic to neurons (Zielasek and Hartung, 1996). Indeed, many 
studies also reveal the toxic and cell death-inducing potential of cytokine, such as 
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TNF-α, for neurons and oligodendrocytes. The microglial mediators may induce 
secondary reactions in endogenous or infiltrated cells, which are harmful for neuronal 
structures. In addition, microglia can trigger or increase the release of potentially toxic 
agents and neuromodulatory compounds, including glutamate from astrocytes. 
Cytokines and chemokines of microglial origin assist in the process of leukocyte 
invasion via enhanced expression of endothelial adhesion molecules and chemotactic 
guidance. Microglia also stimulate lymphocytes by representing antigen in conjunction 
with costimulatory signals and the release of cytokines (Dasguputa et al., 2002). 
Certain (microglial) cytokines appear to have the most critical role in 
neuropathological scenarios. Prime candidates are tumor necrosis factor-α (TNF-α) 
and nitric oxide (NO) (Rothwell and Luheshi 1996; Rothwell 1997).  
 
1.5. Microglial activation in various neurodegenerative diseases 
It is well known that microglia play a key role in mediating inflammatory 
processes, which are associated with various neurodegenerative diseases. Growing 
evidence indicates that amyloid deposition and microglial activation participate in 
inflammatory reactions in the Alzheimer’s disease brain. In AIDS dementia patients, 
progressive neurodegeneration is the consequence of activation of microglia that are 
infected with HIV. In Huntington’s disease, overproduction of complements by 
activated microglia may cause neurodegenration (Singhrao et al., 1999). Nitric oxide 
(NO) produced by microglia plays an important role in the death of dopaminergic 
neurons in MPTP (a neurotoxin used to induce Parkinson's disease) model of 
Parkinson’s disease (Dehmer et al., 2000). In multiple sclerosis, the rapid destruction 
of oligodendrocytes by necrosis is followed by delayed destruction by apoptosis with 
an activated microglia/macrophages invasion (Jamin et al., 2001). Microglial 
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activation also play important roles in the pathogenesis of sponggiform 
encephalopathies (Prion disease) (Rezaie and Lantos, 2001). 
1.6. Alzheimer’s disease and microglial activation 
Alzheimer's disease (AD) is the most common neurodegenerative disorder of 
the elderly, and it is characterized clinically by relentlessly progressive memory loss, 
as well as other cognitive impairments. The neuropathological hallmarks of AD 
include abundant deposits of Amyloid-beta (Aβ) fibrils in senile plaques, massive 
accumulations of abnormal tau filaments (one type of microtuble-associated proteins) 
in neurofibrillary tangles (NFTs), and extensive neuronal degeneration associated with 
profuse reactive microglia (Clark et al., 2000). Apart from the SPs and NFTs, AD 
brains also exhibit a number of additional nondiagnostic pathological abnormalities, 
including a profound loss of synapses, massive neuronal degeneration, extensive 
gliosis, microglial proliferation/activation, and evidence of an unusual inflammatory 
process (Clark et al., 2000).  
1.6.1. Microglial activation induced by Aβ protein 
Amyloid-β (Aβ) is a 39- to 42-amino acid cleavage product of a 
transmembrane glycoprotein, amyloid precursor protein (APP). Synthetic peptide 
homologous to Aβ and its fragments had been utilized to investigate their role in AD 
(Glenner and Wong, 1984). Aβ peptides have been shown to be amyloidogenic under 
experimental conditions and numerous studies have been performed to clarify the 
mechanisms of glial activation in vitro induced by exposure to these molecules. 
Synthetic form of full-length human Aβ promotes neuronal death in the presence of 
microglia (Meda et al., 1995b). In vitro studies have been performed to identify 
specific regions of the Aβ peptide required for eliciting neurotoxicity and microglial 
activation. In this context, several reports have suggested that the amino-terminus of 
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Aβ1-42 contains domains critical for cellular binding and biologic effects such as 
complement activation (Van Muiswinkel et al., 1999). Studies on the structure and 
function of Aβ1-42 have identified a cluster of basic amino acids HHQK  (Aβ13-16), 
which are assumed to act as a plaque-anchoring site for microglia and necessary for 
microglial activation (Giulian et al., 1998). Extensive investigations on the 
cyototoxicity of different regions of Aβ1-42 indicate that fragment of Aβ25-35 is 
biologically active on neuronal and glial cells (Meda et al., 1995b; Pike et al., 1993; 
Yankner et al., 1990). This fragment has been widely used as it lacks the critical N-
terminal site for complement activation and thus allows a selective focus on non-
complement mechanisms such as cytokine signaling. 
1.6.2. Free radicals 
Reactive oxygen species (ROS) including superoxide anions, hydroxy radicals, 
and hydrogen peroxide are generally hazardous to a host of intracellular functions in 
target cells, e.g. membrane properties, energy production and cytoskeletal stability, 
particularly to myelin and its forming cells, oligodendrocytes. LPS and phorbol-12-
myristate-13acetate (PMA) are stimulators of ROS production from cultured microglia. 
Nitriogen oxides such as nitric oxide (NO) are highly reactive free radicals, of which 
nitrite peroxide is the strongest reactive oxygen specie. NO has been implicated in 
neurotoxicity. However, the mechanisms of NO-induced neurotoxicity are still unclear, 
but have been proposed to include the following (1) activation of poly (ADP ribose) 
polymerase followed by NAD and ATP depletion (Zhang et al., 1994), (2) induction of 
apoptosis by poorly defined mechanisms (Uehara et al., 1999), and (3) glutamate 
release (Trabace et al., 2000) and excitotoxicity (Hewett et al., 1994; Leist et al., 1997) 
and inhibition of mitochodrial respiration (Brown, 1999). LPS and β-amyloid are 
known to stimulat NO production from microglia. In the presence of Interferon-γ (INF-
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γ), β-amyloid synergistically stimulates the production of NO and TNF-α (Goodwin et 
al., 1995; Bonaiuto et al., 1997). 
1.6.3. Proinflammatory cytokines 
Tumor necrosis factor-α  (TNF-α), interleukin-1 (IL-1) and interleukin-6 (IL-6) 
are the main proinflammatory cytokines in the CNS, and play a central role in 
modulating inflammatory responses and in astrocyte proliferation (Meda et al., 1996). 
TNF-α is elevated in the serum, cerebrospinal fluid (CSF) and cerebral cortex 
of AD patients (Fillit et al., 1991; Tarkowski et al., 1999). It has been demonstrated 
that Aβ induces the production of TNF-α by activated rodent and human microglia 
(Lue et al., 2001; Meda et al., 1995a; Shalit et al., 1997). Some of Aβ-induced glial 
activities, such as reactive nitrogen intermediate (RNI) and chemokine production 
appear to be mediated through release of endogenous TNF-α  (Meda et al., 1995b; 
Meda et al., 1996; Shalit et al., 1997). Thus, it appears that endogenous synthesis of 
TNF-α, that occurs in Aβ-stimulated microglial cells, may greatly enhance other 
cytokines and free radical production in an autocrine-paracrine manner. While TNF-α 
seems to play a central role in microglial functions, its effect on neuronal cell viability 
is still controversial (Benveniste et al., 1992). For example, TNF-α has been reported 
to be trophic to rat hippocampal neurons (Barger, 1995). On the other hand, transgenic 
mice that overexpress TNF-α exhibit severe inflammation and neurodegeneration 
(Akassoglou et al., 1997). Moreover, TNF-α as well as IL-1 can exert both 
neurotrophic and neurotoxic effects depending on their concentrations, site and 
duration of action (Rothwell et al., 1995). Therefore, even though direct neurotoxic 
effects of TNF-α cannot be excluded in AD, it is likely that TNF-α is indirectly 
neurotoxic, via induction of microglial cells to produce NO (Akama et al., 2000; 
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Combs et al., 2001; Meda et al., 1995b). Hence, it has been suggested that cytokine is 
one of the key mediators in modulating microglial functions in response to Aβ. 
IL-1 has been shown to be produced by both rodent and human glial cells in 
response to Aβ (Araujo and Cotman, 1992; Hu et al., 1998; Johnstone et al., 1999; Lue 
et al., 2001; Meda et al,. 1996). IL-1 is up-regulated within affected cerebral cortical 
regions of AD brain and increased number of IL-1 immunoreactive microglia is 
associated with senile plaques (Griffin et al., 1995; Griffin et al., 1998; Sheng et al., 
1996).  In senile plaques, IL-1 is involved in several functions: a) it could promote the 
synthesis and processing of APP, thus inducing further Aβ production and deposition 
in the plaques (Buxbaum et al., 1992); b) it may trigger production of other cytokines 
in an autocrine fashion (Benvenise, 1992). As further evidence of the importance of 
IL-1 in the pathogenesis of AD, recent genetic studies have shown that the increased 
risk for the development of AD is associated with certain polymorphisms in the genes 
encoding IL-1α and β (Mark et al., 2000).  
IL-6 is a pleiotropic cytokine that mediates immune and inflammatory 
reactions within the CNS. IL-6 is generally viewed as a destructive and 
proinflammatory cytokine, which induces acute phase proteins and increases vascular 
permeability, lymphocyte activation and antibody synthesis (Akiyama et al., 2000). 
However, there is evidence that IL-6 may also have anti-inflammatory action: for 
example IL-6 can inhibit microglia production of TNF-α induced by INF-γ, IL-1 and 
LPS (Benveniste, 1992). Since IL-6 is known to inhibit TNF-α production by 
monocytes, lack of IL-6 release by Aβ-activated phagocytes may represent a positive 








Chemokines constitute a large family of over 50 cytokines that are expressed 
locally in response to inflammatory stimuli and may amplify subsequent tissue 
reactions through their activating and chemotactic functions (Luster, 1998). In the CNS, 
chemokines are known to be produced by microglia and astrocytes (Hayashi et al., 
1995). In particular, monocyte chemoattractant protein-1 (MCP-1) has been localized 
to reactive microglia and mature senile plaques (Ishizuka et asl., 1997). There is 
growing evidence from in vitro studies that chemokine production might have an 
important role in development of AD. It has been demonstrated that murine microglia 
and human monocytes release interleukin-8 (IL-8), MCP-1 and macrophage 
inflammatory protein-1α (MIP-1α) in response to Aβ (Meda et al., 1995a; 1996; 1999). 
The secretion of MCP-1 and IL-8 appear to increase with time, while MIP-1, after an 
initial release, rapidly decreases. In addition, it has been reported that the chemokines 
are also secreted by Aβ stimulated-human microglia isolated from AD brain (Lue et al., 
2001). The reported ability of microglia to secrete chemokines in response to Aβ is of 
considerable importance because they may contribute to plaque-associated 
inflammation and neurodegeneration. Chemokines are chemotactic for microglial cells 
and their local expression in response to Aβ deposition may increase the population of 
microglial cells in senile plaques (Hayashi et al., 1995; Peterson et al., 1997). 
Microglia, once arrived around Aβ deposits, can promote further recruitment and 
activation of other phagocytes, with subsequent amplification of inflammatory 
reactions. Furthermore, since microglia may be induced to express transcripts for APP, 
their recruitment driven by locally secreted chemokines may be involved in 
amyloidogenesis and neurotoxicity. 
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1.6.5. Inhibitory cytokines  
Excessive production of cytokines and free radicals can lead to tissue damage. 
However, specific inhibitors can regulate the secretion and action of proinflammatory 
mediators. For example, inhibitory cytokines, such as interleukin 10 (IL-10) and 
transforming growth factor-β (TGF-β) regulate LPS-induced proinflammatory 
mediators in human microglia (Hu et al., 1999) and in rat glial cells (Ledeboer et al., 
2000). Therefore microglial activation in response to Aβ could also be 
counterbalanced by parallel release of cytokine inhibitors or inhibitory cytokines. 
TGF-β has been detected in plaques and cerebrospinal fluid of AD patients, and in 
particular the isoform 1(TGF-β1) seems to be an important modulator of microglial 
cell activation (Akiyama et al., 2000). TGF-β1 is a potent chemoattractant for 
microglia (Yao et al., 1990), and it increases APP expression, Apolipoprotein E (Apo 
E) production and Aβ deposition (Monning et al., 1994). In contrast to these 
proinflammatory and amyloidogenic properties, TGF-β1 may serve to protect against 
neuronal cell damage (Flanders et al., 1998). On the other hand, TGF-β1 appears to be 
unaltered by Aβ in cultures of mouse microglia and human monocytes (Meda et al., 
1996). In addition, Aβ-stimulated phagocytes do not produce inhibitory cytokines such 
as IL-10 and TGF-β1, suggesting the possibility that an imbalance between 
proinflammatory cytokine and their inhibitors may contribute to the pathogenesis of 
AD.  
 
1.7. Cellular mechanisms of microglial activation 
1.7.1. Signaling cascade in microglia following endotoxin exposure (Fig 1.2) 
Lipopolysacaride (LPS), the standard reagent for microglial activation, acts on 
microglia by its surface-membrane receptor, CD14 (Pugin et al., 1994; Nadeau and 
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Rivest, 2000). The LPS receptor acts as a glycosylphosphatidyliositol (GPI)-anchored 
membrane glycoprotein (Andersson et al., 1992) and its interaction with LPS leads to 
tyrosine kinase activation and cytokine gene transcription through the translocation of 
nuclear factor kappaB (NF-κB) from cytoplasm to nucleus. While the activation of this 



















Fig. 1.2. Signaling pathways following microglial stimulation with LPS. LPS acts via LPS 
receptor (CD14) to trigger a kinase cascade resulting in increased gene transcription of TNF-α 
and iNOS. (Adapted from Pocock and Liddle, 2001). 
 
microglia, prolonged stimulation may cause inflammation in neurodegenerative 
diseases (Gonzalez-Scarano and Baltuch, 1999). Microglial stimulation by LPS via the 
LPS receptor leads to nitric oxide production via activation of tyrosine kinase and 
iNOS (Lockhart et al., 1998). Activation of microglia by LPS also results in the 
production of nitric oxide and TNF-α together with the activation of the MAP kinases 
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and p38 (Bhat et al., 1998). Inhibition of ERK or p38 prevents iNOS and TNF-α 
production. 
1.7.2. Signaling pathways activated in microglia during aging and Alzheimer's 
disease 
Exposure of microglia to amyloid fibrils results in elevated expression of the 
immediate early genes c-fos and junB (Meda et al., 1995; Yates et al., 2000). Certain 


































Fig. 1.3. Signaling pathways in microglia stimulated by Aβ peptides. Aβ peptides act at 
microglia receptor resulting in the activation of kinase cascade and/or generation of reactive 
oxygen species (ROS). The tyrosine and MAP kinase cascades result in gene transcription, 
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to plaques as well as sites that drive microglial activation (Giulian et al.,1996). Aβ 
peptides may interact with at least four different microglia receptor; the scavenger 
receptor (El Khoury et al., 1996; Paresce et al., 1996), the receptor for glycated end 
products (RAGE) (Yan et al., 1996), the serpin-enzyme complex receptor (Boland et 
al., 1996) and an unidentified receptor coupled to tyrosine and MAP kinase signaling 
pathways (McDonald et al., 1997; 1998). Interaction between the scavenger receptor 
and Aβ peptides elicits the phagocytosis by microglia (Paresce et al., 1996; Huang et 
al., 1999). Binding of Aβ to RAGE or the tyrosine kinase coupled receptor elicits 
production of reactive oxygen species (El Khoury et al., 1996; Yan et al., 1996; 
McDonald et al., 1997). Superoxide production by RAGE has been proposed to occur 
by extracellular signaling pathways rather than by intracellular signaling pathways that 
mediate ROS generation by the tyrosine kinase pathway (McDonald et al., 1997). 
Fibrillar forms of Aβ peptides (in particular fibrillar Aβ1-40 and Aβ25-35) rapidly 
activate a tyrosine kinase-dependent signaling pathway and superoxide production in 
microglia mediated by the Src family members such as tyrosin kinase Lyn and Syk and 
FAK (McDonald et al., 1997).  
Exposure of microglia to Aβ results in the phophorylation and activation of a 
number of transcription factors, including NF-κB. Expression of proinflammtory genes 
is critically dependent on the activation of NF-κB (Baldwin, 1996). The regulation of 
NF-κB is extraordinarily complex and not all elements regulating its activation have 
been defined. Immune stimulation of myeloid lineage cells leads to the activation of 
this transcription factors through unknown upstream elements, leading to the 
phosphorylation and activation of IκB kinases (IKK) that are organized in a large 
multiprotein complex. NF-κB (comprised of p50 and RelA p65 subunits) exists in an 
inactive state in the cytoplasm via its association with the inhibitory subunit IκB, 
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which serves to make its nuclear localization signal (NSL) (Baldwin, 1996). Activation 
of NF-κB requires the initial phosphorylation of the inactive IKK. Upon 
phosphorylation of its catalytic subunits, IKK binds to the inactive NF-κB-IκB 
complex and phosphorylates IκB (Delhase et al., 1999). The phosphorylated IκB 
dissociates from the p65/p50 complex and the activated NF-κB translocates to the 
nucleus and promotes transcriptional activation of a number of genes. 
 
1.8. Inhibitors of microglial activation 
Non-steroidal anti-inflammatory drugs (NSAIDs): Administration of the 
NSAIDs, indomethacin (Netland et al., 1998) or ibuprofen (Lim et al., 2000) to 
transgenic animal models of AD results in a significant inhibition of the number of 
reactive microglia associated with the amyloid plaques. Thus, the results of these 
animal studies are similar to those observed in AD patient populations treated with 
NSAIDs (Mackenzie and Munoz, 1998). In addition, exposure of transgenic APP 
expressing mice to high levels of ibuprofen for 6 months resulted in an approximate 
50% reduction of cortical Aβ levels and plaque density (Lim et al., 2000). The basis of 
this effect is presently unclear. 
cAMP-Related Molecules:  Intracellular cAMP level is a key factor in a 
variety of cell functions. In the case of cultured microglia, cAMP reduces cellular 
functions in general. In addition, LPS-stimulated production of TNF-α is also inhibited 
(Woo et al., 2003). 
Endogenous Molecules:  Many other endogenous molecules are reported to 
inhibit microglial activation. The anti-inflammatory cytokine, IL-10 inhibits LPS-
induced IL-1β and TNF-α production in microglia (Sawada et al., 1999). Treatment 
with vitamin E reduces LPS-induced NO, IL-1α, and TNF-α production in microglia 
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(Li et al., 2001). Apolipoprotein E and its mimetic peptides downregulate the LPS-
induced production of TNFα and NO in microglia (Laskowitz et al., 2001). α-
Melanocyte-stimulating hormone (MSH) reduces Aβ-induced production of NO and 
TNF-α by microglial cells (Galimberti et al., 1999) and melatonin inhibits Aβ-induced 
production of IL-1β and IL-6 in brain slices (Clapp-Lilly et al., 2001). 
 
1.9. Retinoids  
All-trans-retinoic acid (RA) is an active metabolite of retinol (vitamin A). 
Therapeutic use of RA or its congeners in skin diseases and cancer, and its toxicity in 
embryonic development, has attracted great attention (Mangelsdorf et al., 1994). 
Another important function of the vitamin A is that it plays a role in enhancing 
immunity. Links between vitamin A deficiency and infectious diseases have been 
known for a long time. The immunologic effects of vitamin A appear to be primarily 
mediated through its major acid metabolites, all-trans-retinoic acid and 9-cis-retinoic 
acid, which are important ligands to a family of nuclear transcription factors known as 
retinoid receptors (Mangelsdorf et al., 1994). Retinoids exert their effects through their 
ability to bind to and activate a number of nuclear receptors which function as 
transcriptional factors and, in turn, regulate the expression of the retinoid target genes 
(Mangelsdorf et al., 1994). The retinoid nuclear recptors are members of the 
steroid/thyroid hormone family of receptors. Two classes of retinoid receptors have 
been identified, i.e., the retinoic acid receptors (RARs) and the retinoid X receptors 
(RXRs) (Gudas, 1992). RARs are activated by both trans retinoic acid (RA) and 9-cis-
retinoic acid (9-cis-RA), while the RXRs are activated only by 9-cis-RA (Heyman et 
al., 1992; Levin et al., 1992). Three subtypes, designated α,β and γ exist for each class 
(Allegretto et al., 1993; Keidel et al., 1994; Ostrowski et al., 1995). Each receptor 
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subtype has also been demonstrated to have multiple forms due to differential splicing 
and promoter usage. Two major isoforms exist in RARα and γ: RARα1 and RARα2 
(Leroy et al., 1991), and RARγ1 and RARγ2 (Kastner et al., 1990; Giguere et al., 
1990). In the case of RARβ, there are four major isoforms; RARβ1, RARβ2, RARβ3 
and RARβ4 (Zelent et al., 1991; Nagpal et al., 1992). Although homologous 
redundancy exists among the RARs, recent studies have demonstrated that the various 
receptor subtypes may possess separate functions (Nagpal et al., 1992) 
Activation of the RARs and RXRs requires the dimerization of these receptors 
(Dawson et al., 2000). While RARs may only dimerize with RXRs, RXRs can 
homodimerize as well as dimerize with the vitamin D, thyroid hormone and a number 
of orphan receptors (Dawson et al., 2000). Thus activation of RXRs can result in the 
signaling among numerous pathways. The dimeric receptors can then bind to target 
genes containing specific nucleotide sequences termed retinoic acid response elements 
(RAREs) or retinoid X response elements (RXREs) which are located in the promoter 
regions of the DNA. The RARs have been found to bind to a number of RAREs. In 
general, the RAREs have been found to bind direct repeats of AGGTCA which are 
separated by five or two nucleotides; however they can be palindromic, inverted or 
more complex in nature (Mangelsdorf et al., 1994). RXR-RXR homodimers bind to 
RXREs (5'-AGGTCA-3') in which the half sites are separated by a single base pair 
(Mangelsdorf et al., 1990).  
RARs and RXRs can modulate gene function indirectly through their 
interactions with other transcription factors and thus modify their activities. The 
activator protein-1 (AP-1) complex consists of a dimer composed of members of the 
Jun-Fos family of proteins that in turn bind to AP-1 consensus sequences located in the 
promoter of genes. The cyclic AMP response elements binding protein (CBP) bind Jun 
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in the AP-1 dimer to stimulate transcription from AP-1 sites. In the presence of 
retinoids, the retinoid receptors form a complex with CBP and thus inhibit its ability to 
activate the AP-1 complex (Kamei et al., 1996). CBP has also been found to function 
as a coactivator in RAR and RXR signaling (Chakravarti et al., 1996). 
The principal effects of retinoids on target cells are growth inhibition and 
induction of differentiation.  Retinoids have also been shown to exert 
immunomodulatory and anti-inflammatory activities (Brinckerhoff et al., 1983). 
However, the mechanism responsible for these functions is not well understood. 
Retinoids have been shown to regulate macrophage functions such as phagocytosis 
(Goldman, 1984), accessory cell function (Katz et al., 1987), the synthesis of certain 
enzymes i.e., transglutaminase (Chiocca et al., 1988) and collagenase (Brinckerhoff et 
al., 1983). 
1.9.1. Expression pattern of RARs and RXRs in cultured cell lines 
Mouse and human embryonal carcinoma (EC) cell lines and the promyelocytic 
leukemia cell line HL60 have been widely used as the model systems to study retinoid- 
induced differentiation. All major RAR isoforms are expressed in mouse P19 and F9 
EC cells (Leroy et al., 1991; Zelent et al., 1991; Kastner et al., 1990); RARα1,RARγ, 
and γ2 are expressed constitutively, but the four RARβ isoforms, as well as RARα2, 
require the presence of RA to be expressed (Zelent et al., 1989; Leroy et al., 1991; 
Zelent et al., 1991; Hu et al., 1990). Upregulation of RARβ expression by RA has also 
been observed in a number of cell lines, including hepatocarcinoma HepG2 cells (De 
et al., 1989), tracheobronchial PCC4 cells (Nervi et al., 1990), and S91 melanoma cells 
(Clifford et al., 1990). RARβ transcripts are also induced by RA in primary cultures of 
human dermal fibroblasts, but not keratinocytes (Elder et al., 1991), which correlates 
with the specific induction of RARβ transcripts in mouse dermis observed by in situ 
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hybridyzation (Viallet et al., 1991). In RA-treated P19 cells, the level of RXRα mRNA 
appears to be increased, whereas that of RXRβ is unchanged, and that of RXRγ is 
decreased. In contrast, RXRα mRNA levels appear to be decreased by RA treatment of 
promyelocytic leukima cells HL60 and NB4 (Perez et al., 1993). 
1.9.2. RARs and RXRs in adult mouse tissues 
The multiple RAR isoforms display differential expression patterns in mouse 
adult tissues. RARα1 is expressed in all tissues examined, similar to expression pattern 
of a housekeeping gene (Zelent et al., 1989; Leroy et al., 1991). The expression 
patterns of RARα2, RARβ and RARγ1 and γ2 appear to be more restricted in adult 
mouse tissues (Zelent et al., 1989; Zelent et al., 1991; Kastner et al., 1990). The three 
RXRs display different expression patterns. In the adult mouse, RXRα is expressed at 
high levels in liver, skin, and intestine; at lower levels in a variety of other tissues; and 
at undetectable levels in brain (Mangelsdorf et al., 1992). RXRβ appears to possess a 
rather ubiquitous and uniform expression pattern (Mangelsdorf et al., 1992). RXRγ is 
expressed at high levels in heart and muscle, and at lower levels in brain, liver, and 
kidney (Mangelsdorf et al., 1992). 
1.9.3. Expression of retinoids in embryos 
The transcripts of RARα, β and γ as well as RXR genes display specific 
spatiotemporal patterns of distribution (Ruberte et al., 1990; Ruberte et al.,1991; Dolle 
et al., 1989; Dolle et al., 1990) in the embryo. RARα is expressed almost ubiquitously, 
whereas RARβ and RARγ exhibit more restricted and complex expression patterns. 
RARβ, but not γ, is also expressed in a number of nervous structures, which suggests 
that this receptor could play some specific function during neural development. 
RARβ was of particular interest in the current study because of the strongest 
RARE promoter activity (Sucov et al., 1990) and the important role it played in the 
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cancer and liver research. The decreased expression of RARβ mRNA by hepatic 
stellate cells (HSC) isolated from rat liver fibrosis animal model was reported (Weiner 
et al., 1992). The subsequent studies confirmed suppressed mRNA expression of RAR 
in the HSC in vivo, and the exposure of HSC to retinoic acid normalized the level of 
both RARβ and RA (Motomura et al., 2001). 
 
2.0. Aims of this study 
Microglia, which were ignored by neuroscientists for years since its 
identification as a unique cell type in the CNS, have gained tremendous attention 
recently due primarily to voluminous studies showing its functional importance in the 
disease processes in the CNS. Most of the studies for the last few decades had focused 
on the origin and pathological roles of microglia in the CNS. Information on the 
involvement of microglial activation in neurodegenerative diseases has increased 
considerably and a number of investigations have been carried out to identify the 
inhibitor of microglial activation. The main objectives of the current study are: 
1. To examine the effects of RA on β-amyloid or LPS-induced TNF-α and iNOS 
mRNA expression in the primary culture of microglia. It is hypothesized that 
RA suppresses expression of proinflammatory cytokines in the microglia 
stimulated by β-amyloid or LPS. 
2. To examine whether RA receptor β was involved in the RA-induced inhibition 
of microglial activation. 
3. To explore the mechanism by which RA modulates the gene expression of 
cytokines in the activated microglia. 
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                                                          Materials & Methods 
2.1. Animals and Microglia cultures 
Totally 500 Sprague-Dawley strain rats (postnatal 3-5-day) were used. In the 
handling and care of all animals, the International Guiding Principles for Animal 
Research, as stipulated by the World Health Organization (1985) and as adopted by the 
Laboratory Animal Center, National University of Singapore, were followed. All rats 
were bred and supplied by the Laboratory Animal Center, National University of 
Singapore, and were kept in the department of Anatomy Animal House before the 
experiments. 
 Culture medium was changed after 3 days and then twice a week. Microglial 
cells were isolated from high-density glial cell cultures. The details are as follow: 
2.1.1. Removal of Brain Tissue   
The rats were deeply anesthetized with 3.5% chlorohydrate and were 
decapitated. The heads were briefly dipped in and out of 70% ethanol and were washed 
five times with cold PBS. The skin was cut along the midline in a caudal to rostral 
direction and was pulled to the side to expose the skull. The skull was penetrated with 
a tip of a pair of scissors medially just caudal to the cerebral hemispheres. This point 
was easy to penetrate as it lies at the juncture of two major sutures of the skull bone. 
The skull was cut rostrally to the nose and from there it was cut mediolaterally. Also, 
from the original point of incision the skull was cut mediolaterally and then in a rostral 
direction reaching the first set of cuts. In this way, two roughly rectangular flaps of 
skull were cut and then removed. Underlying tissue was moistened with cold PBS. A 
pair of curved forceps was run around and under the hemispheres to free them up and 
scoop out the cortex. The brain tissue was placed onto a 100-mm-diameter dish with 
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PBS on ice and was rinsed three times. The cortices were collected into a 50-ml tube 
with PBS on ice and were rinsed three times by pouring off PBS washes. Finally, the 
rat cortices were placed onto a 60-mm-diameter dish on ice. 
2.1.2. Cleaning of Desired Tissue 
The unwanted brain region, such as olfactory bulb, basal ganglia, hippocampus, 
and thalamus, which would have variably carried over in the initial crude removal of 
the cerebral hemispheres, was removed firstly. The meninges and superficial vessels 
were removed subsequently. The remaining tissue was transferred to a new 60-mm-
diameter dish, containing cold PBS, on ice. The tissue was finely cleaned further to 
remove the remaining meninges and vasculature from the dish. 
2.1.3. Tissue Chopping 
A long pair of serrated forceps or hemostats was used to chop the tissue in the 
dish with gentle up-and-down motion. Any tissue trapped between the blades was 
rinsed with some solution after chopping. The tissue pieces were collected and 
transferred into a 50-ml sterile conical tube on ice with a 25-ml plastic pipet. 
2.1.4. Enzymatic Digestion 
Tissue pieces were allowed to settle to the bottom of tube and then supernatant 
was discarded. 7 ml DMEM medium (Sigma Cat. No. D1152) with 0.5mg/ml Trypsin 
– EDTA were added into the tube and mixed. The tube was placed at a 45° angle in a 
shaking water bath at 37°C, 75 strokes/min, for 3 min. The tube was tabbed for 30s, 
the nondissociated tissue was allowed to settle down and the supernatant was 
discarded. The dissociation step was repeated for 6 min and the solution was triturated 
seven times with 10ml pipet; supernatant containing dissociated cells was collected 
into tube on ice with an equivalent half-volume of serum. 
 
 




2.1.5. Mechanical dissociation of remaining tissue fragments 
1 ml DNase solution (50µg/ml Dnase I Sigma Cat. No. D4527) was added and 
triturated seven times with transfer pipet (3.5 ml, graduated; Sarstedt Catalog No. 
86.1172.001) in 15-ml conical tube. The solution was settled and the supernatant was 
collected. The above step was repeated three more times. Any remaining 
nondissociated tissue was discarded. 
2.1.6. Centrifugation, Removal of Debris, and Osmolality Changes 
All the collected cell suspensions were pooled and, using 50ml centrifuge 
tubes, 20- to 25-ml volumes of BSA solution per tube were layered over. This step was 
done gently so as not to disturb interface between the two fluids. The cells were 
centrifuged at 250g for 10 min.  
2.1.7. Viable Cell Count 
The cells were resuspended in approximately 40 ml completed medium. Two 
samples of 1.8 ml were taken and combined with 0.2ml of 0.4% trypan blue in DMEM 
medium. After 10 min the hemocytometer was used to enumerate viable (trypan blue-
excluding) cells. Finally cell suspensions were centrifuged (10 min × 250g) and plated 
at a density of 1.2 ×106 cells/ml in culture medium consisting of DMEM supplemented 
with 10% fetal calf serum.  
After 2 weeks, the loosely adherent microglial cells were recovered by shaking. 
After centrifugation (100×g for 5 min), viable cells were plated at a final density of 1.0 
×106 cells/well on a 6-multiwell Falcon plate or 2.5 ×105 cells/well on 24-multiwell 
plate in DMEM supplemented with 10% fetal calf serum. Nonadherent cells were 
removed 30 min after plating by changing the medium for neuronal maintenance 
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medium and purified microglia were incubated for 24h before use. For 
immunocytochemistry, 12-mm glass coverslips coated with L-lysine were used. 
2.1.8. Purity of microglia 
The purity of microglia was assessed immunohistochemically using 
Lycopersicon esculentum (tomato) lectin (1:100; Sigma, Cat. No. L0401), a marker for 
microglia, and Propidium iodide (PI) (20µg/ml;Sigma, Cat. No. 70335) a nuclear 
marker of all cells attached to the coverslips. Also, the cellular morphology was 
examined under a phase contrast microscope. The purity of microglia cultures was 
found to be around 96%.  
 
2.2. Treatment of cultures 
To study the effects of Aβ25-35, the active fragment of full length Aβ peptide, 
and LPS on microglial activation, cells were incubated in 75cm2 flasks for 6h in the 
presence of Aβ25-35 (50µg/ml; Sigma Cat No. A4559) or LPS (1µg/ml; Sigma Cat No. 
L2762). Microglia were plated onto 24-wells (1×105 cells/well) and then exposed to 
Aβ25-35 or LPS in the presence or absence of RA. All-trans retinoic acid (RA; Sigma, 
R2625) was dissolved in 85% ethyl alcohol and stored at -20°C. Immediately before 
use, the stock solution was diluted to the desired concentrations with the DMEM. Pure 
microglia were allowed to grow for 1day before incubation with 0.1µM, 1µM, 10µM 
of RA in the presence or absence of 50µg/ml of Aβ25-35 or 1µg/ml of LPS for 6h. Cells 
have been checked everyday under the microscope to avoid possible fungi and other 
microorganism growth. 
2.3. Principles of Real time RT-PCR 
Many cellular decisions concerning survival, growth and differentiation are 
reflected in altered patterns of gene expression and the ability to quantitate 
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transcription levels of specific genes has always been central to any research in gene 
functions (Zamorano et al. 1996). The methods used to quantify mRNA include 
techniques based upon hybridization (e.g., Northern blotting, solution hybridization, 
and RNase protection assays) as well as the amplification of individual RNA 
molecules by combining reverse transcription and the polymerase chain reaction (RT-
PCR). The RT-PCR technique has been shown to correlate with the more traditional 
hybridisation methods (Murphy et al., 1990; Noonan et al., 1990). In addition, RT-
PCR may be more sensitive because it exponentially amplifies small amounts of 
nucleic acid. This sensitivity enables the detection of rare mRNAs, mRNAs from small 
amounts of tissue, and mRNAs that are expressed in mixed cell populations. The 
conventional RT-PCR is a complex assay and all physical and chemical components of 
the reaction are interdependent.  
Recent advances in quantitative RT-PCR technology include the development 
of real-time quantitative RT-PCR (Heid et al., 1996). Real-time RT-PCR incorporates 
specific technology to detect the PCR product following each cycle of the reaction. 
Several methods are available to detect the DNA generated by real-time RT-PCR 
including the SYBR green I minor groove DNA-binding dye (Wittwer et al., 1997). 
Real-time RT-PCR allows sensitive detection of the DNA product, ensures detection 
during the linear range of amplification, eliminates the need for post-PCR analysis, and 
incorporates specialized software to simplify data analysis. 
2.3.1. DNA-binding dyes 
This method involves detection of the binding of a fluorescent dye (SYBR 
Green) to DNA (Morrison et al. 1998). The unbound dye exhibits little fluorescence in 
solution, but during elongation, increasing amounts of dye bind to the nascent double-
stranded DNA. This results in an increase in the fluorescence signal that can be 
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observed during the polymerisation step, and that decreases when the DNA is 
denatured. Consequently, fluorescence measurements at the end of the elongation step 
of every PCR cycle are performed to monitor the increasing amount of amplified 
DNA. This method obviates the need for target-specific fluorescent probes, but the  
 
Dye incorporation method. (A) During denaturation, unbound SYBR Green I dye exhibits little 
fluorescence. (B) At the annealing temperature, a few dye molecules bind to the double-
stranded primer/target, resulting in light emission upon excitation. (C) During the 
polymerisation step, more and more dye molecules bind to the newly synthesised DNA, and 
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the increase in fluorescence can be monitored in real-time. (D) On denaturation, the dye 
molecules are released and the fluorescence signal returns to background. 
specificity is determined entirely by the specific primers. In addition, the specificity 
and RT-PCR product verification can be achieved by plotting fluorescence as a 
function of temperature to generate a melting curve of the amplicon (Ririe et al., 
1997). This is done by slowly increasing the temperature above the melting 
temperature (Tm) of the amplicon and measuring the florescence. As the Tm of the 
amplicon depends markedly on its nucleotide composition, it is possible to identify the 
signal obtained from the correct product. A characteristic melting peak at the Tm of the 
amplicon will distinguish it from amplification artifacts that melt at lower temperatures 
in broader peaks. 
2.3.2. Quantification of real-time PCR 
Two different methods of analysing data from real-time, quantitative PCR 
experiments exist: absolute quantification and relative quantification. Absolute 
quantification determines the input copy number of the transcript of interest, usually by 
relating the PCR signal to a standard curve. Relative quantification describes the 
change in expression of the target gene relative to some reference group such as an 
untreated control or a sample at time zero in a time-course study.  
Absolute quantification should be performed in situations where it is necessary 
to determine the absolute transcript copy number. Absolute quantification can be 
combined with real-time PCR. In some situations, it may be unnecessary to determine 
the absolute transcript copy number and reporting the relative change in gene 
expression would suffice. For example, stating that a given treatment increased the 
expression of gene X by 2.5-fold may be more relevant than stating that the treatment 
increased the expression of gene X from 1000 copies to 2500 copies per cell.  
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Quantifying the relative changes in gene expression using real-time RT-PCR 
requires certain equations, and assumptions, and the testing of these assumptions to 
properly analyze the data. The 2-∆∆Ct method fits well to calculate the relative changes 
in gene expression determined from real-time quantitative PCR experiments. 
Derivation of the 2-∆∆Ct equation, including assumptions, experimental design, and 
validation tests, has been described in Applied Biosystems User Bulletin No. 2 (P/N 
4303859). 
2.3.3. Threshold cycle 
The concept of the threshold cycle (Ct) is at the heart of accurate and 
reproducible quantification using fluorescence-based RT-PCR (Higuchi et al. 1993). 
Fluorescence values are recorded during every cycle and represent the amount of 
product amplified to that point in the amplification reaction. The more templates 
present at the beginning of the reaction, the fewer number of cycles it takes to reach a 
point in which the fluorescent signal is first recorded as statistically significant above 
background (Gibson et al., 1996). This point is defined as the Ct, and always occurs 
during the exponential phase of amplification.  
2.3.4. Selection of Internal Control and Calibrator for the 2-∆∆Ct method 
The purpose of the internal control gene is to normalize the PCRs for the 
amount of RNA added to the reverse transcription reactions. We have found that 
standard housekeeping genes usually suffice as internal control genes. Suitable internal 
controls for real-time quantitative PCR include β-actin, GAPDH, β2-microglobulin, 
and rRNA. It is highly recommended that the internal control gene be properly 
validated for each experiment to determine that gene expression is unaffected by the 
experimental procedures. 
2.3.5. Real-time PCR Data analysis:  
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The data generated from SYBR green method can be analyzed in the following 
manner. The real-time PCR data are plotted as the ∆Rn = (Rn+) - (Rn-), where Rn+ is the 
fluorescence signal of the product at any given time and Rn- is the fluorescence signal 
of baseline emission during cycles 6 to 15. An arbitrary threshold is set at the midpoint 
of the log ∆Rn versus cycle number plot. The Ct value is defined as the cycle number 
at which the ∆Rn crosses this threshold. The fold change in target gene relative to the 
β-actin, endogenous control is determined by:  
Fold change = 2∆∆Ct,   (Livak and Schmittgen, 2001) 
where ∆∆Ct= (CtTarget - CtTActin)Time x - (CtTarget - CtTActin)Time 0. Time x is any time point 
and time 0 represents the expression of gene under certain conditions. Relative 
quanifica-tion of gene expression using the 2∆∆Ct method may be correlated with the 
absolute gene quantification obtained using standard curves (Winder et al., 1999). 
Statistical significance was estimated as the fold induction among the various groups 
by Student’s t-test. Results were considered as significant at p<0.05. 
Procedures of Real-time RT-PCR 
2.4.1. Extraction of total RNA 
Total RNA was extracted from the cells using RNeasy Mini Kit (QIAGEN, 
Cat. No. 75161 ) according to the manufacturer's instructions. At least 2.5 ×106 cells 
were used to extract the total RNA. Cells were lysated in 500µl of Buffer RLT 
(containing a highly denaturing guadinium isothiocyanate which inactivates RNase) 
and then scrapped from the flask with the scrapper. The lysate was homogenized and 
then centrifuged for 30s at 14,000g in a microfuge as the superatant was mixed with 
500µl of 70% ethanol to clear lysate. The sample was applied to an RNeasy mini spin 
column (silica-gel membrane, maximum binding capacity is 100µg of RNA longer 
than 200 bases) and spun for 30sec at 10,000g and flow-through was discarded. During 
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this step, the total RNA binds to the membrane. The RNA bound to the membrane was 
washed with buffer RW1 and RPE sequentially. High-quality RNA was then eluted in 
20µl of RNase free water. The concentration and purity of the extracted RNA was 
evaluated spectrophotometrically at 260 and 280nm (Biophotomelter, Eppendorf, 
Germany)  
2.4.2. cDNA Synthesis  
The cDNA synthesis was carried out in a total volume of 25µl containing the 
RNA template, Oligo(dT)15 Primer (Promega, USA,  Cat. No. C1101), M-MLV 
Reverse transcriptase (Promega USA, Cat. No. M1701) Reverse transcriptase buffer 
(Promega, USA, Cat No. M1701), dNTP (QIAGEN, Cat. No. 210210), RNase 
inhibitor (Promega USA, Cat. No. N2511) and RNase-free water (QIAGEN, Cat. No. 
210210). 
2µg of RNA was added with 1µl Oligo(dT)15  primer into a microcentrifuge 
tube and then heated to 70°C for 5 min to melt secondary structure within the template. 
The tube was immediately transferred to ice and the sample was spun briefly. The 
following components were added to the annealed primer/template in the order shown. 
 
                              M-MLV 5× Reaction Buffer                            5µl 
   10 × dNTP Mix                                                1.25µl 
     RNase inhibitor                                                0.675µl 
                              M-MLV Reverse transcriptase                        1µl 
RNase free water to final volume                     25µl 
The reaction mix was mixed gently and incubated for 1h at 42°C. Finally it was 
heated to 95°C for 5min. The cDNA synthesized was kept at 4°C.  
2.4.3. Real-time PCR operation 
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Using the LightCycler instrument (Roche Molecular Biochemicals), the PCR 
was performed in a total volume of 10 µl, containing 2µl DNA, 10 pmol of each primer, 
1µl SYBR Green I (Roche Molecular Biochemicals), 4 mM MgCl2 and water to the 
final volume. The sequence of the primers and the PCR conditions for each primer 
with SYBR Green I are given in Table 2.1 and 2.2. During the entire program, we used 
the maximum temperature transition rate of 20°C/s. This quantification program was 
followed by a melting program to detect the melting points for every PCR product. 
2.4.4. Detection of PCR products 
PCR products were run on agarose gel using electrophoresis. 2% agarose gel 
was prepared by heating agarose in the TAE buffer (0.04M Tris-base, 0.001M EDTA,  
Table 2.1: PCR primers for the real-time PCR assay 
Gene Primer (Forward) Primer (Reverse) Size (bp)
β-actin tcacccacactgtgcccatctacga ggatgccacaggattccataccca 314 
TNF-α cccagaccctcacactcagat gtccaagagaagttccctgtt 215 
iNOS cgtgtgcctgctgccttcctgctgt gtaatcctcaacctgctcctcactc 623 
RARβ ggctaccactatggcgtcag tgctctggggtatacctgg 554 
TGF-β1 gagagccctggataccaactactg gatgtaaacctcggacctgtgtg 173 
 
Table 2.2 PCR cycling conditions for the gene studied 
 β-actin TNF-α iNOS RARβ TGF-β1 
Denaturation 95°C  15 s 95°C  15 s 95°C  15 s 95°C  15 s 95°C  15 s 
Annealing 60°C 10s   57°C 10s   68°C 10s   60°C  10s 60°C  10s  
Extension 72°C 12.5s   72°C  8.6s 72°C  25s 72°C  22s 72°C  7s 
Cycles 50 50 50 50 50 
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Glacial acetic acid, pH 7.8). Ethidum bromide was added into the gel and the  gel was 
cooled, poured onto a gel tray and allowed to solidify. 8µl of each real-time PCR 
product was loaded in each lane of the gel and electrophoresed at 110V for 45min in 
TAE buffer along with 10µl of 100bp DNA ladder (Promega). 
 
2.4.5. Analysis of Real-time PCR bands 
The PCR products appeared as bands in gel and were visualized with an 
ultraviolet trans-illuminator and photographed (Polaroid). The 100bp DNA ladder was 
used to determine the size of the amplified DNA from 100-1500bp. 
 
2.5. Immunohistochemistry 
2.5.1. Principles of immunohistochemistry 
Immunohistochemistry (IHC), or immunocytochemistry, is a method for 
localizing specific antigens in tissues or cells based on antigen-antibody recognition. 
The basic critical principle of IHC is a sharp localization of target components in the 
cell and tissue, based on a satisfactory signal-to-noise ratio. A series of technical 
developments in IHC have created sensitive detection systems and the most commonly 
used is the enzyme-labeled system (for light microscope); the fluorescent dye-labeled 
system (for fluorescence microscope); and the electron-dense particles-labeled system 
(for electron microscope). To achieve greater sensitivity is always the critical issue for 
the IHC and a large number of detection techniques have been developed, including 
peroxidase antiperoxidase (PAP), avidin-biotin conjugate (ABC) and biotin-
streptavidin (B-SA) methods.  
The routine procedure for IHC includes fixation, blocking, the incubation with 
first antibody and the detection of first antibody. Fixation is required for the IHC to 
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stabilize the tissues or cells and protect them from the rigors of subsequent processing 
and staining techniques. Blocking of nonspecific background staining is recognized to 
enhance the specificity of the primary antibody. There are two aspects to the blocking 
of background staining of tissues: nonspecific antibody binding and the presence of 
endogenous enzymes. Nonspecific antibody binding is generally more of a problem 
with polyclonal antibody, because multiple "unwanted" antibodies may exist in 
antiserum. Another form of nonspecific binding may result from the fact that 
antibodies are highly charged molecules and may bind nonspecifically to tissue 
components bearing reciprocal charges (e.g. collagen). Such nonspecific binding may 
lead to localization of either the primary antibody or the labeled moiety (conjugate, 
PAP, and so on), producing false-positive staining of collagen and other tissue 
components of sufficient degree to obscure specific staining. Since antibody molecules 
can not be seen with the light microscope, they are labeled or flagged by some method 
that permits their visualization. The detection system can be divided into direct 
conjugate-labeled antibody method and indirect conjugate-labeled antibody method 
and the latter is generally more accurate than the former. In the direct detection 
method, a label has attached to an antibody by chemical means and then is directly 
applied to the tissue section or cells. All labeled antibody methods performed by the 
indirect procedure are strictly analogous in principle. The primary antibody that has 
specificity against the antigen in question (e.g., rabbit anti-A), is added to the section; 
the excess is washed off. The labeled secondary antibody, which has specificity against 
an antigenic determinant present on the primary rabbit antibody is then added; it serves 
to label the sites of tissue localization of the primary antibody, which, in turn, is bound 
to the antigen. 
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2.5.2. Procedures of immunohistochemistry  
2.5.2.1. Fixation  
Microglia attached to the cover slip were allowed to grow for 1 day before 
being incubated with 50µg/ml of Aβ25-35 or 1µg/ml of LPS in presence or absence of 
10µM RA for 6h. 4% paraformaldehyde was used to fix the cells for 30 min. 
Materials: 
0.1M phosphate-buffered saline (PBS): 
            Di-sodium hydrogen phosphate heptahydrate              13.3g 
Sodium chloride                                                        8.5g 
Distilled water                                                           1000ml 
           The solution was adjusted to pH7.4 with 1N hydrochloric acid. 
 
PBS containing 0.1% Triton-X 100 (PBS-TX): 
Triton-X 100                        1ml 
           PBS                                           1000ml 
2% bovine serum albumin (BSA) (Sigma A-7030): 
BSA                                                                                      2g 
PBS                                 100ml 
Table 2.3. Source and concentration of primary antibodies 
Primary antibody Source (Cat. No.) Dilution 
TNF-α Chemicon (AB 1837P) 1:100 
iNOS Chemicon (AB5328) 1:400 
NF-κB (p65 subunit) Santa Cruz (SC-109) 1:100 
PI Sigma (70335) 20µg/ml 
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Table 2.4. Source and concentration of seconday antibodies 
Secondary antibody Source (Cat. No.) Dilution 
Anti - Rat  Biosource (ACI 0408) 1:200 
Anti - Rabbit Snta Cruz (AB5328) 1:200 
 
2.5.2.2. Procedure: 
The coverslips that were taken to detect the immunoreactivity of TNF-α, iNOS 
and NF-κB proteins were rinsed in phosphate buffered saline (PBS) and incubated at 
room temperature (24ο C) for 16 h with the polyclonal antibodies of TNF-α, iNOS and 
NF-κB. Double-immunofluorescence labeling study was carried out between different 
primary antibodies directed against TNF-α, iNOS and NF-κB(p65 subunit) and PI, a 
nuclear marker. In this connection, different primary antibodies and PI were applied 
simultaneously. Subsequent detection of primary antibodies was also carried out using 
fluorochrome-conjugated secondary antibodies and examined under a Carl Zeiss 
LSM410 confocal microscope. The source and concentration of primary and secondary 
antibodies and PI are listed in Table 2.3. and 2.4. A semiquatitative analysis of the 
extent of NF-κB translocation was carried out by counting 8 fields of ~50 cells in the 
control, and LPS or Aβ treated microglia cultures in the presence or absence of RA 
(10µM). The cells with red nuclei were counted as NF-κB translocation negative; the 
cells with yellow nuclei were counted as NF-κB translocation positive. Each 





































 Results  
Primary cultures of microglia cells with approximately 96% purity were 
prepared from early postnatal rat brain. These cells were considered to be microglia as 
they were stained with lectin that is a known marker for microglia (Figs. 1A-C). Since 
it is generally accepted that microglial cells in culture are activated to certain extent 
during preparation procedure (Slepko and Levi, 1996), microglia in vitro exhibit 
reactive phenotype and produce some amount of cytokines that are specific for reactive 
microglia. In this study, microglia have been stimulated by Aβ25-35 and LPS, and 
treated with RA. The cells treated with Aβ or LPS appear round in shape with 
abundant cytoplasmic inclusions (Figs. 1B, C). Since microglia begin to proliferate 2-3 
days after the activation (Streit WJ et al., 1999), 6h treatment of Aβ25-35 or LPS dose 
not affect the proliferation of microglia.  
1. RA inhibits Aβ- or LPS-induced expression of TNF-α in microglia 
The effects of different concentrations of RA at 0.1µM, 1µM, and 10µM on 
TNF-α mRNA expression in microglia after 6h of treatment with Aβ or LPS have been 
analyzed by real time PCR (Figs. 2 and 3). Both Aβ and LPS induced TNF-α mRNA 
expression levels at 6-folds and 116-folds respectively. RA inhibited the induction of 
TNF-α expression by Aβ and LPS in a dose-dependent manner (0.1-10µM). The 
inhibitory effects of RA on TNF-α expression ranged from 29% to 57% in the Aβ25-35 
treated culture (Fig. 2) and from 94% to 97% in the LPS treated culture (Fig. 3).The 
maximum inhibition was detected with 10µM RA on both Aβ- and LPS-induced TNF-
α mRNA expression in comparision to that of cultures stimulated by LPS/ Aβ25-35.  
Immunohistochemically, TNF-α positive cells were hardly detectable in the 
untreated microglia cultures (Figs. 4A-C and 5A-C). Aβ25-35 and LPS markedly 





F). These cells appeared to be reactive as they showed increase in size and abundant 
cytoplasm with cytoplasmic inclusions. Significantly, RA (10µM) reduced the 
intensity of TNF-α positive staining and number of TNF-α positive cells in both Aβ- 
and LPS- treated cultures (Figs. 4G-I, 5G-I). Furthermore, the cells displayed 
phenotypic features as in the untreated cultures. 
 
2. RA inhibits Aβ- or LPS-induced expression of iNOS in microglia  
The effect of RA on Aβ or LPS-induced gene expression of iNOS in microglia 
has also been analyzed by real time PCR (Figs. 6 and 7). Aβ and LPS induced iNOS 
mRNA expression level to 8-folds and 500-folds respectively in the microglia culture. 
RA suppressed the induction of iNOS expression in a dose-dependent manner in both 
Aβ and LPS treated microglia cultures and the suppressive effects ranged from 61% to 
95% in the Aβ-treated culture (Fig. 6) and from 92% to 96% in the LPS-treated culture 
(Fig. 7).  
The immunohistochemical data show that iNOS-positive cells were 
undetectable in the untreated microglial cultures (Figs. 8A-C). In LPS-treated cultures, 
intensely stained iNOS positive cells were found to be increased significantly (Figs. 
8D-F). RA (10µM) reduced the intensity of iNOS positive staining and number of 
iNOS positive cells in the LPS- treated cultures (Figs. 8G-I).    
 
3. RA increases the RARβ and TGF-β1 mRNA expression in microlglia  
In view of the fact that that RA exerts its effects via RA receptors, we have 
investigated whether the RA directly inhibits microglial activation by altering the 
expression of its receptors in the microglia. Although there are several types of RA 





time PCR analysis showed that RA induced the RARβ mRNA expression in a dose-
dependent manner from 2.25-flod to 22-folds in Aβ-treated cultures (Fig. 9), and from 
17-folds to 68-folds in LPS-treated culture (Fig. 10). Neither Aβ nor LPS increased the 
RARβ gene expression significantly in the microglial culture devoid of RA.  
Since RA is known to induce expression of TGF-β1 which inhibits iNOS gene 
expression (Defacque et al, 1999; Vodovotz et al, 1996), it is hypothesized that the 
observed attenuation of iNOS by RA could be mediated via an effect on TGF-β1 
mRNA expression. The real time PCR analysis showed that 10µM and 0.1µM of RA 
significantly enhanced the TGF-β1 gene expression in the Aβ- and LPS-treated 
cultures respectively (Figs. 11 and 12). 
 
4. RA attenuates the NF-κB translocation from cytoplasm to nucleus in LPS-
treated microlglia 
Since several studies have emphasized a dominant role for NF-κB as an 
essential factor for the induction of iNOS and TNF-α, and the interaction between RA 
and the NF-κB has been well documented in different cell types (Hur et al., 1999; Park 
et al., 2003), we have examined the effect of RA on the  NF-κB translocation in LPS-
treated microglia. In the untreated microglia cultures, NF-κB was localized in the 
cytoplasm but not in the nucleus of microglia (Figs. 13A-C). The treatment with LPS 
(1µg/ml) induced the NF-κB translocation from cytoplasm to the nucleus in the 
microglial cell (Figs. 13D-F). The nuclear translocation of NF-κB was detected in 40% 
of the microglial cells treated with LPS (Fig. 14). However, the number of nuclear 




































This study demonstrates that RA inhibits the neurotoxic effect of microglia by 
suppressing the expression levels of TNF-α and iNOS induced by Aβ and LPS. The 
direct involvement of RA on the inhibition of microglial activation has been further 
confirmed as it increases the expression level of its receptor RARβ on microglia.  
Microglial activation and associated induction of proinflammatory cytokines 
and NO have been well documented in various neurodegenerative diseases such as 
Alzheimer's disease, Parkinson's disease, etc. (Uno et al, 1997; Jellinger, 2000). It is 
believed that the activated microglia exert cytotoxic effects in the brain through two 
different processes such as phagocytosis of cellular debris and releasing of a large 
variety of potentially noxious substances (Banati et al., 1993). Both TNF-α and iNOS 
have been implicated as important mediators of the inflammatory response and they 
contribute to the majority of the neurotoxic activity exerted by the activated microglia 
(Combs et al., 2001).  
TNF-α, as well as the IL-1, are the two major proinflammatory cytokines with 
pleiotropic functions, produced by microglia and blood-derived macrophages during 
CNS inflammation. In cultured microglia, synthesis and secretion of TNF-α is induced 
by pathogens or pathogen components (mainly LPS). TNF-α has been implicated in 
the development of CNS inflammation mainly through their ability to induce 
expression of adhesion molecules and chemokine synthesis in cerebrovascular 
endothelial cells and astrocytes, which facilitate leukocyte extravasation into the CNS 
(Lee and Benveniste, 1999). Recent studies in transgenic mice overexpressing TNF-α 
in the CNS suggest that intracerebrally produced TNF-α may be involved in initiating 
CNS tissue destruction and inflammation (Akassoglou et al., 1997), as well as in 





NO which is produced by the action of nitric oxide synthase(NOS), possesses a 
diverse array of physiologic functions, such as muscle relaxation, neuronal activity, 
and immune modulation (Grisham et al., 1999). As a free radical, NO is one of the 
major contributors to the formation of reactive nitrogen species. On the other hand, NO 
directly reacts with proteins, especially heme-containing enzymes, such as guanylate 
cyclase, cytochrome P450, hemoglobin, and cyclooxygenase, to modulate their 
functions. In addition, NO can react with membrane lipids to induce lipid peroxidation. 
Indirectly, the combination of NO and superoxide can form highly reactive 
intermediates, such as peroxynitrite, that can induce DNA strand breaks, lipid 
peroxidation, and protein nitration (Beckman, 1996). 
 Although the microglial activation is elicited by neuronal damage, it has been 
widely accepted that their cytotoxic effects in turn contribute to the pathogenesis of 
neurodegeneration (Kalaria, 1999; Streit et al., 1999). Hence, understanding the 
mechanisms that inhibit microglial activation may provide insights into potential 
interventions for immune mediated neurodegenerative diseases. Several mediators 
such as Vitamin E (Li et al, 2001), estrogen (Vegeto et al., 2001), apolipoprotein E and 
its mimetic peptides (Laskowitz et al, 2001), minocycline (Wu et al., 2002) and 
Vitamin D3 (Lefebvre et al., 2003) have been shown to be involved in the inhibition of 
microglial activation. In a mixed microgliia-neuronal coculture, it has been 
demonstrated that Vitamin E has indirect neuroprotective effects through suppression 
of microglia activation by LPS.  
Estrogen has been shown to exert an anti-inflammatory activity in primary 
cultures of rat microglia exposed to LPS. It suppressed the transformation of microglia 
into reactive phenotype and production of inflammatory mediators such as iNOS, 





al., 2001). Vitamin D3 has also been shown to inhibit the production of TNF-α and NO 
by stimulated microglia (Lefebvre et al., 2003).  
All-trans-retinoic acid (RA) is an active metabolite of Vitamin A, and it acts 
through a family of nuclear transcription factors known as retinoid receptors (Napoli, 
1996). While the principal effects of RA on target cells are inhibition of proliferation 
and induction of differentiation (Maden, 2002), it has also been shown to exhibit 
immunomodulatory and anti-inflammatory activities in various cell types (Besnard et 
al., 2002; Mathew and Sharma, 2000). RA has been demonstrated to induce TNF-α 
mRNA destabilization in an RXR dependent manner in the rat hepatic macrophages 
(Motomura et al., 2001). In addition, RA has been shown to inhibit the production of 
both TNF-α and NO from activated peritoneal macrophages in a dose and time 
dependent manner (Mehta and Sharma, 1994). In the present study, it has been found 
that RA inhibits the mRNA expression of TNF-α and iNOS that are associated with 
microglial activation by LPS or Aβ. Inhibitory effects of RA on microglia activation 
may be directly via RARβ as the mRNA expression level of RARβ was found to be 
increased in the RA-treated microglia.  
The reactive microglia in neurodegenerative diseases produce increased 
amount of NO which either directly or through its highly toxic derivative peroxynitrite 
augments neurotoxicity in the CNS (Possel et al., 2000). Inducible NOS, which is a 
calcium independent enzyme, is responsible for the production of large amount of NO. 
Several proinflammatory cyokines including TNF-α have been shown to induce iNOS 
expression (Knerlich et al., 1999). In the present study, RA inhibits the expression of 
both TNF-α and iNOS and NF-κB nuclear translocation in the activated microglia. A 
mechanistic link between iNOS and NF-κB has been demonstrated as the iNOS 





further confirmed as the iNOS expression is inhibited by downregulation of NF-κB 
activity (Pahan et al., 1997).  In addition, it has been shown that NF-κB forms a 
transcriptionally inactive complex with retinoid-activated RXR (Na et al., 1999). The 
RXR forms heterodimeric complex of RARβ/RXR (Soprano et al., 1998) through 
which RAR-dependent signaling is transduced. Taken together, it is suggested that RA 
acts on the microglia via RARβ which downregulates the NF-κB transcriptional 
activity thereby iNOS expression is inhibited in stimulated microglia exposed to RA. 
In addition, RA-induced inhibition of TNF-α expression in the stimulated microglia is 
likely to be NF-κB dependent as it has been reported that inhibition of active NF-κB 
nuclear translocation by the SN-50 peptide prevents the Aβ-stimulated increase of 
TNF-α promoter activity (Combs et al., 2001).   
TGF-β1 acts as an immunosuppressor and inhibits the production of 
inflammatory cytokines by stimulated microglia (Suzumura et al., 1993; Chao et al., 
1995) and expression of iNOS in the smooth muscle (Perrelle et al., 1994,1996). RA 
has been shown to induce TGF-β1 expression in the various cell types (Defacque et al., 
1999; Cosgaya et al., 1997).  In the present study, up-regulation of TGF-β1 expression 
observed in the activated microglia treated with RA could contribute to the inhibition 
of iNOS expression which might be mediated through altered activity of NF-κB (Xie 
et al, 1994) as TGF-β1 has been reported to increase the expression of IκB, the 
inhibitor of NF-κB (Arura et al., 1996).  
The present study demonstrates the mechanisms by which RA suppresses the 
LPS-/Aβ-induced expression of TNF-α and iNOS in the primary cultures of rat 
microglia. It is suggested that RA could be a potential therapeutic agent to reduce the 
inflammatory response in the neurodegenerative diseases. 
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Microglia, which were ignored by neuroscientists for several years since its 
identification as a unique cell type in the CNS, have gained tremendous attention in 
recent years due to voluminous studies showing its functional importance in the CNS 
disease processes. Microglia play a major role in the regulation of immune and 
inflammatory activities as well as tissue remodeling in the central nervous system 
(Streit et al, 1999). It plays a beneficial role in neuronal cell viability and survival by 
producing growth factors and removing potentially toxic cellular debris (Kreutzberg, 
1996). On the other hand, the activated microglia in neurodegenerative diseases, 
secrete a wide range of neurotoxic mediators, which augment the neurodegeneration 
(Boje and Arora, 1992; Chao et al., 1992).  
 Neuronal cell death occurs in a number of neurodegenerative diseases 
including Parkinson’s disease, Alzheimer’s disease, prion diseases, and HIV-dementia. 
In each, an inflammatory process in the CNS is believed to play an important role in 
the pathway leading to neuronal cell death. The inflammatory response is mediated by 
microglia that normally sense and respond to neuronal damage and remove the 
damaged cells by phagocytosis. However in pathologic circumstances, the activated 
microglia can cause neuronal damage through the expression of neurotoxic cytokines 
and other inflammatory mediators (Giese et al., 1998; Bianca et al., 1999). It is 
important to understand mechanisms involved in regulation of microglial activation for 
identification of therapeutic targets and potential development of treatment strategies 
for neurodegenerative diseases. The main objective of this study was to identify the 
therapeutic agents that inhibit neurotoxicity caused by inflammatory reaction of 
activated microglia in response to neurodegeneration. 
Retinoic acid (RA), the biologically active form of vitamin A, is known to act 
as a potent antiproliferative and anti-inflammatory compound. RA has been shown to 
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exert anti-inflammatory effect and attenuate the production of inflammatory mediators 
such as TNF-α and iNOS in various cell types besides its crucial role in the regulation 
of cell proliferation and differentiation (Mehta et al., 1994; Datta et al., 2001). It is 
well known that RA modulates the target cell activity by binding to RA receptors and 
that RA receptors modulate gene transcription by directly binding to promoters 
containing a retinoic acid receptor element (RARE) or via antagonistic cross-coupling 
of transcription factors such as NF-κB  (Xu et al., 1997). Recent studies showed that 
RA receptors regulate inflammation in different cell types (Motomura et al., 2001; 
Grummer et al., 2000). Presence of RA receptor on the brain macrophages suggested 
that RA might help prevent the development of microglial-related inflammatory events 
in neurodegenerative diseases and may be the potential therapeutic agent for the 
treatment of neurodegenerative diseases. The hypothesis tested in the present study 
was that the RA suppresses microglial activation in neurdegenerative disease 
conditions. 
Based on the results obtained, a hypothetical pathway for RA-induced 
suppression of TNF-α and iNOS in the activated microglia has been derived as 
follows: The exposure of microglia to Aβ or LPS enhanced the mRNA expression 
levels of TNF-α and iNOS. RA inhibited the expression levels of both TNF-α and 
iNOS in microglia exposed to Aβ or LPS. Further, the RA-induced inhibition of TNF-
α and iNOS expression appears to be mediated via inhibition of NF-κB translocation. 
RA may inhibit the NF-κB translocation in two possible ways (Fig. 5.1): 1. RA 
elevates the expression level of RARβ which may form a heterodimeric complex of 
RARβ/RXR (Soprano et al., 2002). This complex may in turn form a transcriptionally 
inactive complex with NF-κB by unknown mechanisms (Na et al., 1999). The down- 
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Fig. 5.1 A hypothetical pathway by which RA inhibits experession of TNF-α and 
iNOS in Aβ or LPS treated microglia 
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regulation of the NF-κB activity may lead to inhibition of TNF-α and iNOS expression 
as reported by others (Combs et al., 2001; Xie et al., 1994); 2.  Up-regulation of TGF-
β1 by RA may increase the expression of IκB, the inhibitor of NF-κB activity thereby 
expression levels of TNF-α and iNOS may be decreased. 
The present study demonstrates the mechanisms by which RA suppresses the 
LPS-/ Aβ-induced expressions of TNF-α and iNOS in the primary cultures of rat 
microglia. It is suggested that RA could be a potential therapeutic agent to reduce the 
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Fig. 1.  Confocal images of microglia labeled with lectin and Propidium iodide (PI), a 
nuclear marker. Red fluorescence indicates PI; green fluorescence denotes 
immunostainning of lectin. The purity of microglia was estimated to be around 96%. 
(A) Control; (B) Microglia treated with 50µg/ml Aβ for 6h; (C) Microglia treated with 

























Fig. 2.  Real time PCR analysis demonstrating the inhibitory effects of RA on TNF-α 
mRNA expression induced by Aβ in the primary microglia cultures. (A) After the 
treatment with Aβ, mRNA expression level of TNF-α was elevated to six-fold in 
comparison to that of the control. RA treatment suppressed TNF-α gene expression 
significantly in a dose dependent manner in Aβ treated microglia. Data represent mean 
± standard deviation (n=4). Significant differences between Aβ and RA + Aβ groups 
are indicated by *p<0.01. (B) The melting curve of the real-time PCR with the single 
peak shows the specificity of the product. (C) The PCR product of TNF-α (215bp) 
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Fig. 3. Real time PCR analysis demonstrating the inhibitory effects of RA on TNF-α 
mRNA expression induced by LPS in the primary microglia cultures. (A) After the 
treatment with LPS, mRNA expression level of TNF-α was elevated to 116-fold in 
comparison to that of the control. RA treatment suppressed TNF-α gene expression 
significantly in a dose dependent manner in LPS treated microglia. Data represent 
mean ± standard deviation (n=4). Significant differences between LPS and LPS + RA 
group are indicated by *p<0.01. (B) The melting curve of the real-time PCR with the 
single peak shows the specificity of the product. (C) The PCR product of TNF-α (215) 
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Fig. 4. Confocal images of microglia showing TNF-α immunoreactivity (green) and 
nuclear marker PI (red). In the control group (A-C), a few weakly stained TNF-α 
positive cells were detectable. The number of TNF-α positive cells was increased in 
the primary cultures treated with Aβ (D-F) for 6h. These cells appear to be increased in 
size and show abundant cytoplasm with numerous cytoplasmic inclusions (arrows). 
10µM of RA (G-I) decreased the staining intensity and the number of TNF-α positive 
cells in the primary cultures treated with Aβ. These cells appear smaller and display 








































Fig. 5. Confocal images of microglia showing TNF-α immunoreactivity (green) and 
nuclear marker PI (red). In the control group (A-C), a few weakly stained TNF-α 
positive cells were detectable. The number of TNF-α positive cells was increased in 
the primary cultures treated with LPS (D-F) for 6h. These cells appear to be increased 
in size and show abundant cytoplasm with numerous cytoplasmic inclusions. 10µM of 
RA (G-I) decreased the staining intensity and the number of TNF-α positive cells in 
the primary cultures treated with LPS. These cells appear smaller and display reduction 


































Fig. 6. Real time PCR analysis demonstrating the inhibitory effects of RA on iNOS 
mRNA expression induced by Aβ in the primary microglia cultures. (A) After the 
treatment with Aβ, mRNA expression level of iNOS was elevated to eight-folds in 
comparison to that of the control. RA treatment suppressed iNOS gene expression 
significantly in a dose dependent manner in Aβ treated microglia. Data represent mean 
± standard deviation (n=4). Significant differences between Aβ and Aβ + RA group 
are indicated by *p<0.01. (B) The melting curve of the real-time PCR with the single 
peak shows the specificity of the product. (C) The PCR product of iNOS (623) loaded 
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Fig. 7. Real time PCR analysis demonstrating the inhibitory effects of RA on iNOS 
mRNA expression induced by LPS in the primary microglia cultures. (A) After the 
treatment with LPS, mRNA expression level of iNOS was elevated to 500-fold in 
comparison to that of the control. RA treatment suppressed iNOS gene expression 
significantly in a dose dependent manner in LPS treated microglia. Data represent 
mean ± standard deviation (n=4). Significant differences between Aβ and Aβ+RA 
group are indicated by *p<0.01. (B) The melting curve of the real-time PCR with the 
single peak shows the specificity of the product. (C) The PCR product of iNOS (623) 
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Fig. 8.  Confocal images of microglia showing iNOS immunoreactivity (green) and 
nuclear marker PI (red). In the control group (A-C), a few weakily stained iNOS 
positive cells were detectable. The number of iNOS positive cells was increased in the 
primary cultures treated with LPS (D-F) for 6h. These cells appear to be increased in 
size and show abundant cytoplasm with numberous cytoplasmic inclusions. 10µM of 
RA (G-I) decreased the staining intensity and the number of iNOS positive cells in the 
primary cultures treated with LPS. These cells appear smaller and display reduction of 




































Fig. 9. RARβ mRNA transcripts (554 bp) were amplified from microglia of both 
untreated and Aβ treated culture in presence or absence of different concentrations of 
RA by RT-PCR. (A) After the treatment with Aβ, mRNA expression level of RARβ 
was unchanged in comparison to that of the control. RA treatment elevated RARβ 
gene expression significantly in a dose dependent manner in Aβ treated microglia. Data 
represent mean ± standard deviation (n=4). Significant differences between Aβ and Aβ 
+ RA groups are indicated by *p<0.01. (B) The melting curve of the real-time PCR 
with the single peak shows the specificity of the product. (C) The PCR product of 
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Fig. 10. RARβ mRNA transcripts (554 bp) were amplified from microglia of both 
untreated and LPS treated culture in presence or absence of different concentrations of 
RA by RT-PCR. (A) After the treatment with LPS, mRNA expression level of RARβ 
was unchanged in comparison to that of the control. RA treatment elevated RARβ 
gene expression significantly in a dose dependent manner in LPS treated microglia. 
Data represent mean ± standard deviation (n=4). Significant difference between Aβ 
and Aβ + RA groups are indicated by *p<0.05, **p<0.01. (B) The melting curve of the 
real-time PCR with the single peak shows the specificity of the product. (C) The PCR 
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Fig. 11.  Real time PCR analysis shows that RA enhanced TGF-β1 mRNA expression 
in microglia induced by Aβ. No alteration in the level of TGF-β1 mRNA expression 
was detected in microglia treated with Aβ. However, RA at 10µM concentration 
induced the TGF-β1 mRNA expression significantly. Data represent mean ± standard 
deviation (n=4). Significant differences between Aβ treated cultures and RA+Aβ 
treated cultures are indicated by *p<0.01. (B) The melting curve of the real-time PCR 
with the single peak shows the specificity of the product. (C) The PCR product of 
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Fig. 12. Real time PCR analysis shows that RA enhanced TGF-β1 mRNA expression 
in microglia induced by LPS. No alteration in the level of TGF-β1 mRNA expression 
was detected in microglia treated with LPS. However, RA at 0.1µM concentration 
induced the TGF-β1 mRNA expression significantly. Data represent mean ± standard 
deviation (n=4). Significant differences between LPS treated cultures and RA+LPS 
treated cultures are indicated by *p<0.01. (B) The melting curve of the real-time PCR 
with the single peak shows the specificity of the product. (C) The PCR product of  
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Fig. 13.  Confocal images of microglia labeled with NF-κB (green) and PI (red). In 
control group (A-C), NF-κB was restricted to the cytoplasm of microglia (arrows in 
C). NF-κB translocated into the nuclei (arrows in F) and overlapped (orange) with the 
PI after treatment with LPS for 6h.  RA (10µM) decreased the translocation of NF-κB 









































Fig. 14. Quantitive analysis showing attenuation of NF-κB translocation by RA in 
microglia treated with LPS. Data represent mean ± standard deviation (n=4). 
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